Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report
about
Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)A focused review of the pathogenesis, diagnosis, and management of tumor lysis syndrome for the interventional radiologistRasburicase in the management of tumor lysis: an evidence-based review of its place in therapyRituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.Pediatric lymphomas and histiocytic disorders of childhoodInternational Pediatric Non-Hodgkin Lymphoma Response Criteria.The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis.Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.Tumor Lysis Syndrome in Patients with Hematological Malignancies.
P2860
Q26745670-75EF0678-5714-48A5-874A-CE8189C3CB32Q27012513-C8C5EC9C-9AC7-4418-9F88-DEC20B67E93BQ28082089-49DF1F35-E525-4944-8274-66DFA428686BQ34344942-BC5CE7A8-12C8-4878-AFC0-091235AB7CD7Q34605894-AA039A61-B100-4D68-B32A-34802D8CE693Q35708769-0C7CBB87-F536-4DAD-8441-0F448CF90E84Q36204470-DEAB4A5A-B2F0-4152-A601-4BF90E780399Q37629599-2C5F4495-1835-4DD6-BEB9-BC25ECA3C5C6Q38687541-A0EC2A03-D42F-44DF-8D1F-F5586B4D91F5Q38782141-36A08BC8-6E66-46E9-84C3-899B949A313EQ40597967-393A534E-D7FD-4CD9-80A1-8B06B4CA86D1Q41968809-9638CBE3-6CA5-422A-A9C8-029C6D05239AQ46949121-F9B8C926-E3EB-405B-96C4-DDD83B65D1C6
P2860
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rasburicase in the prevention ...... ildren's Oncology Group Report
@en
Rasburicase in the prevention ...... ldren's Oncology Group Report.
@nl
type
label
Rasburicase in the prevention ...... ildren's Oncology Group Report
@en
Rasburicase in the prevention ...... ldren's Oncology Group Report.
@nl
prefLabel
Rasburicase in the prevention ...... ildren's Oncology Group Report
@en
Rasburicase in the prevention ...... ldren's Oncology Group Report.
@nl
P2093
P2860
P356
P1476
Rasburicase in the prevention ...... ildren's Oncology Group Report
@en
P2093
Jessica Hochberg
Lauren Harrison
Mitchell S Cairo
Paul J Galardy
Sherrie L Perkins
Stanton Goldman
P2860
P304
P356
10.1111/BJH.12542
P407
P577
2013-09-06T00:00:00Z